Reaction
Bone Density Increased reporting signals
As of the last recalculation, Bone Density Increased appears in 395 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 177.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 49 | 177.5 | 178.1 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 58 | 152.8 | 153.2 |
| Naproxen Sodium Tablet, Coated | 31 | 130.8 | 131.1 |
| Naproxen Sodium, Coated Tablets | 31 | 130.8 | 131.1 |
| Naproxen Sodium 220Mg | 31 | 130.6 | 130.9 |
| Triamcinolone Acetonide | 58 | 115.8 | 116.0 |
| Human Immunoglobulin G | 25 | 68.1 | 68.2 |
| Somatropin | 59 | 49.6 | 49.6 |
| Adalimumab-Fkjp | 32 | 39.5 | 39.6 |
| Adalimumab-Aaty | 32 | 38.7 | 38.7 |
| Sulfasalazine | 49 | 37.5 | 37.6 |
| Abatacept | 50 | 21.6 | 21.6 |
| Asfotase Alfa | 4 | 21.2 | 21.3 |